Furthermore, single-nucleotide polymorphisms associated with neuroblastoma risk, such as rs7585356, were shown to alter microRNA binding within the BARD1 3’ untranslated region (3’UTR), further linking genetic variation to isoform-specific expression control [111]. The gene discussed is BARD1; the disease is neuroblastoma.